SHARE SHARE Tribune stock sale leaves company vulnerable to hedge fund noted for ‘cutting fees for the bone’ CLOSE The biotech has designed a process that employs a affected individual’s personal cells for personalized cure. It can use the funding to go after scientific trials for its first therapy. You https://businesstribune.org